Clinical Pharmacology Insights that Accelerate Drug Development

As clinical pharmacology comprises more than 50% of a drug label, the need to understand how to optimize safety and efficacy in drug development is critical to your program. Are you feeling daunted by the task of planning your drug’s clinical development? Well, you’ve certainly come to the right place. In Raj’s Corner, we’ve assembled a series of expert blog posts that will explain clinical pharmacology best practices that support the most streamlined and informative clinical development program. Dr. Rajesh Krishna is currently a Senior Director at Certara’s Integrated Drug Development group. He has more than 20 years of drug development experience with past leadership roles in product value enhancement and quantitative clinical pharmacology at Merck, Aventis, and Bristol-Myers Squibb.
Contact Us

rajesh krishna (1)

Rajesh Krishna

Rajesh Krishna, PhD is a Senior Director in Integrated Drug Development at Certara Strategic Consulting.  Rajesh came to Certara after a rich 20+ years of pharmaceutical industry experience in translational and clinical development at Merck, Sanofi (legacy Aventis), and Bristol-Myers Squibb.  He has contributed to 40+ INDs, more than 200 Phase 1/1b studies; and to the worldwide registration of 9 new molecular entities.

How Can We Help?

Back to top